FDA approves heart drug for black patients.
The Food and Drug Administration's approval in June 2005 of a heart failure drug aimed at black patients marks the first time that the agency has approved a drug for a specific racial group. When added to standard heart failure therapy, BiDil dramatically reduces death and hospitalization in blacks.